Skip to main content

CX Institutional

SEC CIK
0001737089
Latest filing
Jul 1, 2026

ABT holding history

Abbott Laboratories in every 13F filed by CX Institutional, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
94,489
Value
$8.57M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ABT by CX Institutional, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202694,489$8.57M0.2%+14,257+17.8%AddedHolders
Q1 202680,232$8.24M0.3%+52,723+191.7%AddedHolders
Q4 202527,509$3.45M0.1%−1,766−6.0%ReducedHolders
Q3 202529,275$3.92M0.1%+4,310+17.3%AddedHolders
Q2 202524,965$3.40M0.1%−39,807−61.5%ReducedHolders
Q1 202564,772$8.59M0.3%+50,529+354.8%AddedHolders
Q4 202414,243$1.61M0.1%+1,790+14.4%AddedHolders
Q3 202412,453$1.42M0.1%−428−3.3%ReducedHolders
Q2 202412,881$1.34M0.1%+397+3.2%AddedHolders
Q1 202412,484$1.42M0.1%+1,920+18.2%AddedHolders
Q4 202310,564$1.16M0.1%−11,006−51.0%ReducedHolders
Q3 202321,570$2.09M0.1%−38,551−64.1%ReducedHolders
Q2 202360,121$6.55M0.3%+2,818+4.9%AddedHolders
Q1 202357,303$5.82M0.3%+8,445+17.3%AddedHolders
Q4 202248,858$5.36M0.3%+16,222+49.7%AddedHolders
Q3 202232,636$3.16M0.2%+21,894+203.8%AddedHolders
Q2 202210,742$1.17M0.1%−849−7.3%ReducedHolders
Q1 202211,591$1.37M0.1%+781+7.2%AddedHolders
Q4 202110,810$1.52M0.1%+64+0.6%AddedHolders
Q3 202110,746$1.27M0.1%+798+8.0%AddedHolders
Q2 20219,948$1.15M0.1%+31+0.3%AddedHolders
Q1 20219,917$1.19M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.